Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2018-2023
Historical Year
2024-2032
Forecast Year
Dysmenorrhea Market: Competitor Landscape
In October 2023, Mithra Biotech, a company dedicated to women’s health received approximately USD 3 million investment from Fuji Pharma. With the investment, Mithra envisions at redefining fem health by delivering innovative products in the domain of menopause as well as contraception. This also indicates the rising trend of growth in fundings to expand product portfolios.
The key features of the dysmenorrhea market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Novartis AG
- Bayer AG
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd
- Sanofi
- Pfizer Inc.
- GlaxoSmithKline PLC
- Focus Consumer Healthcare
- Johnson & Johnson
- Alvogen
- Amgen Inc.
- Boehringer Ingelheim International GmbH.
- Ipsen Pharm
- Spectrum Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Dysmenorrhea Market Report Snapshots
Dysmenorrhea Market Regional Analysis
Dysmenorrhea Treatment Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The market is anticipated to grow at a CAGR of 5.7% during the forecast period of 2024-2032, driven by the growing incidence of uterine fibroids, endometriosis and adenomyosis.
The market demand is driven by increased interest in improving women’s reproductive health with natural remedies and technological innovations in healthcare.
The major market trend revolves around the rising application of combination treatment methods to treat dysmenorrhea. Oral contraceptive pills are being tested as a potential intervention and have demonstrated positive results in management. There is growing investigations in developing better surgical management methods as well.
Based on treatment types, the market is divided into non-steroidal anti-inflammatory drugs (NSAIDs) and hormonal therapy.
Who are the major end users in the market?
Major end users include hospitals, homecare, and speciality clinics.
It includes primary and secondary dysmenorrhea.
The major regions of the market include the United States, Japan, EU-4 which is segmented into Germany, France, Italy, Spain, and the United Kingdom.
Key players involved in the market are Novartis AG, Bayer AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Sanofi, Pfizer Inc., GlaxoSmithKline PLC, Focus Consumer Healthcare, Johnson & Johnson, Alvogen, Amgen Inc., Boehringer Ingelheim International GmbH., Ipsen Pharm, Spectrum Pharmaceuticals, Inc., and Takeda Pharmaceutical Company Limited.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124